Literature DB >> 30293120

Kaposiform hemangioendothelioma without cutaneous involvement.

Yi Ji1, Siyuan Chen2, Lizhi Li3, Kaiying Yang4, Chunchao Xia5, Li Li6, Gang Yang4,7, Feiteng Kong8, Guoyan Lu9, Xingtao Liu10.   

Abstract

PURPOSE: We sought to characterize the clinical features and management of patients diagnosed as Kaposiform hemangioendothelioma (KHE) without cutaneous involvement.
METHODS: The electronic patient chats at six Triple A hospitals in China were searched to find all patient diagnoses with KHE without cutaneous involvement.
RESULTS: Of 30 patients (mean age at diagnosis, 55.6 months), 17 (56.7%) were male. Fourteen (46.7%) patients were associated with Kasabach-Merritt phenomenon (KMP). Patients with KMP were significantly more likely to have lesions involving truck compared to patients without KMP (odds ratio 10.000; 95% confidence interval 1.641-60.921; P = 0.011). Other common complication included severe anemia and decreased range of motion. In the majority of cases (93.3%), the lesions were highly infiltrative and locally invasive with ill-defined margins. Histological examination was required in all patients without KMP for precise diagnosis. In all, 16 (53.3%) patients received corticosteroid treatment, 19 (63.3%) received oral sirolimus treatment, 7 (23.3%) received intravenous vincristine, and 5 (16.7%) patients used propranolol. Patients had varied responses to conventional drugs, whereas all patients receiving sirolimus treatment had better response. In all, three patients (10%) died of disease, all presented with KMP. Feature of these recalcitrant cases (death) included young age, visceral location, extensive involvement, and lack of improvement with high-dose corticosteroids.
CONCLUSIONS: Our study clearly demonstrated that KHE without cutaneous involvement could be associated with important complication, which might result in death or severe morbidity. Increased awareness of KHE without cutaneous involvement is required for early diagnosis and aggressive therapy in an attempt to prevent complication.

Entities:  

Keywords:  Cutaneous involvement; Kaposiform hemangioendothelioma; Kasabach–Merritt phenomenon; Morbidity; Mortality

Mesh:

Substances:

Year:  2018        PMID: 30293120     DOI: 10.1007/s00432-018-2759-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  35 in total

Review 1.  Kasabach-Merritt syndrome: pathogenesis and management.

Authors:  G W Hall
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

2.  Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.

Authors:  Beth A Drolet; Cameron C Trenor; Leonardo R Brandão; Yvonne E Chiu; Robert H Chun; Roshni Dasgupta; Maria C Garzon; Adrienne M Hammill; Craig M Johnson; Brook Tlougan; Francine Blei; Michèle David; Ravindhra Elluru; Ilona J Frieden; Sheila F Friedlander; Ionela Iacobas; John N Jensen; David M King; Margaret T Lee; Stephen Nelson; Manish Patel; Elena Pope; Julie Powell; Marcia Seefeldt; Dawn H Siegel; Michael Kelly; Denise M Adams
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

3.  Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.

Authors:  Zuopeng Wang; Kai Li; Kuiran Dong; Xianmin Xiao; Shan Zheng
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

Review 4.  Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.

Authors:  Chuan Wang; Yanan Li; Bo Xiang; Fuyu Li; Siyuan Chen; Li Li; Yi Ji
Journal:  Pancreas       Date:  2017 May/Jun       Impact factor: 3.327

5.  Sirolimus for the treatment of complicated vascular anomalies in children.

Authors:  Adrienne M Hammill; MarySue Wentzel; Anita Gupta; Stephen Nelson; Anne Lucky; Ravi Elluru; Roshni Dasgupta; Richard G Azizkhan; Denise M Adams
Journal:  Pediatr Blood Cancer       Date:  2011-03-28       Impact factor: 3.167

6.  Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.

Authors:  Israel Fernandez-Pineda; Juan Carlos Lopez-Gutierrez; Gema Ramirez; Catalina Marquez
Journal:  Pediatr Hematol Oncol       Date:  2010-11       Impact factor: 1.969

Review 7.  Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon.

Authors:  Ciara O'Rafferty; Grainne M O'Regan; Alan D Irvine; Owen P Smith
Journal:  Br J Haematol       Date:  2015-06-30       Impact factor: 6.998

8.  Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma.

Authors:  M Sarkar; J B Mulliken; H P Kozakewich; R L Robertson; P E Burrows
Journal:  Plast Reconstr Surg       Date:  1997-11       Impact factor: 4.730

9.  Kaposiform hemangioendothelioma of the mediastinum in a 7-month-old boy: a case report.

Authors:  Daiji Iwami; Satoru Shimaoka; Izumi Mochizuki; Tsutomu Sakuma
Journal:  J Pediatr Surg       Date:  2006-08       Impact factor: 2.545

10.  Kasabach-Merritt phenomenon: a single centre experience.

Authors:  Clodagh Ryan; Vicotria Price; Philip John; Sanjay Mahant; Sylvain Baruchel; Leonardo Brandão; Victor Blanchette; Elena Pope; Miriam Weinstein
Journal:  Eur J Haematol       Date:  2009-11-03       Impact factor: 2.997

View more
  7 in total

Review 1.  Infantile hepatic hemangiomas: looking backwards and forwards.

Authors:  Xue Gong; Yanan Li; Kaiying Yang; Siyuan Chen; Yi Ji
Journal:  Precis Clin Med       Date:  2022-02-11

2.  Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series.

Authors:  Anna Karastaneva; Paolo Gasparella; Sebastian Tschauner; Roman Crazzolara; Gabriele Kropshofer; Manfred Modl; Andreas Pfleger; Ante Burmas; Mirjam Pocivalnik; Raphael Ulreich; Werner Zenz; Wolfgang Schwinger; Besiana P Beqo; Christian Urban; Emir Q Haxhija; Herwig Lackner; Martin Benesch
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

3.  Case Report: Congenital Intracranial Kaposiform Hemangioendothelioma Treated With Surgical Resection.

Authors:  Yingjie Cai; Jiayi Li; Wei Yang; Nan Zhang; Hailang Sun; Weiping Zhang; Ming Ge
Journal:  Front Surg       Date:  2022-04-01

4.  Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.

Authors:  Yi Ji; Siyuan Chen; Suhua Peng; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2019-07-05       Impact factor: 4.123

Review 5.  Kaposiform hemangioendothelioma: current knowledge and future perspectives.

Authors:  Yi Ji; Siyuan Chen; Kaiying Yang; Chunchao Xia; Li Li
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

6.  Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management.

Authors:  Yi Ji; Siyuan Chen; Chuncao Xia; Jiangyuan Zhou; Xian Jiang; Xuewen Xu; Kaiying Yang; Xuepeng Zhang; Feiteng Kong; Guoyan Lu; Yongbo Zhang
Journal:  Orphanet J Rare Dis       Date:  2020-11-07       Impact factor: 4.123

7.  Primary Kaposiform Hemangioendothelioma of the Humerus: A Case Report.

Authors:  Zafar Ali; Syed M Qasim; Farhan Faisal; Gulfam Jameel
Journal:  Cureus       Date:  2022-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.